Predictors of lymphovascular invasion in estrogen receptor positive/Her-2 negative breast cancer patients treated with neoadjuvant chemotherapy

por ÇAVDAR, Eyyüp, İRİAĞAÇ, Yakup
Publicado 2022

A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy

por Şeber, Erdoğan Selçuk, İriagac, Yakup, Çavdar, Eyyup, Karaboyun, Kubilay, Avcı, Okan, Yolcu, Ahmet, Gürdal, Sibel Özkan, Öznur, Meltem
Publicado 2023

Soluble B7H3 level in breast cancer and its relationship with clinicopathological variables and T cell infiltration

por Avci, Okan, Çavdar, Eyyup, İriağaç, Yakup, Karaboyun, Kubilay, Çelikkol, Aliye, Özçağlayan, Tuğba İlkem Kurtoğlu, Öznur, Meltem, Gürdal, Sibel Özkan, Şeber, Erdoğan Selçuk
Publicado 2022

The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

por Akyildiz, Arif, Guven, Deniz Can, Ozluk, Ahmet Anil, Ismayilov, Rashad, Mutlu, Emel, Unal, Olcun Umit, Yildiz, Ibrahim, Iriagac, Yakup, Turhal, Serdar, Akbas, Sinem, Bayram, Ertugrul, Telli, Tugba Akin, Turkoz, Fatma Paksoy, Ozcelik, Melike, Erciyestepe, Mert, Selvi, Oguzhan, Gulbagci, Burcu, Erturk, Ismail, Isleyen, Zehra Sucuoglu, Kahraman, Seda, Akdag, Mutianur Ozkorkmaz, Hamitoglu, Buket, Unek, Ilkay Tugba, Unal, Caglar, Hacibekiroglu, İlhan, Arslan, Cagatay, Azizy, Abdulmunir, Helvaci, Kaan, Demirci, Umut, Dizdar, Omer, Basaran, Mert, Goker, Erdem, Sendur, Mehmet Ali, Yalcin, Suayib
Publicado 2023